SLBTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
SL Science Holding Ltd
Last filing: 20-F on Jun 18, 2026
$1.53+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns SL Science's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ching-Dong Wang | 333,832,129 | 59.53% | 13D (active) amendment | Sep 29, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Ching-Dong Wang | Chief Executive Officer, Director, 10% owner | 333,832,129 | Jun 18, 2026 |
| Ethan Shen PhD | Chief Technology Officer, Director | – | Jun 16, 2026 |
| Lok Sang Leung | Chief Financial Officer | – | Jun 16, 2026 |
| Qian Xu | Director | 20,000 | Jun 17, 2026 |
| John Conrad General | Director | – | Jun 16, 2026 |
| Mingche Liu | Director | – | Jun 16, 2026 |
| Kwo-Liang Chen | Director | – | Jun 16, 2026 |
| Joseph Levinson | Director | – | Jun 15, 2026 |
| Johnson Shun-Pong Lau | – | – | Sep 1, 2026 |